NDC 0409-1109 – Atracurium Besylate
Atracurium Besylate 10 mg/mL · Injection, Solution · Intravenous
Product NDC0409-1109
Product details
- Brand name
- Atracurium Besylate
- Generic name
- Atracurium Besylate
- Labeler
- Hospira, Inc.
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA090782
- Marketed since
- February 25, 2013
- Listing expires
- December 31, 2026
- Pharmacologic class
- Nondepolarizing Neuromuscular Blocker
Active ingredients
- Atracurium Besylate 10 mg/mL
Uses, dosage, side effects and warnings for Atracurium Besylate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0409-1109-01 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-1109-01) / 5 mL in 1 VIAL, SINGLE-DOSE (0409-1109-11) | Feb 25, 2013 |
Other Atracurium Besylate products
- 55150-216 Atracurium Besylate 50 mg/5mL · Injection, Solution · AuroMedics Pharma LLC
- 55150-217 Atracurium Besylate 100 mg/10mL · Injection, Solution · AuroMedics Pharma LLC
- 0409-1105 Atracurium Besylate 10 mg/mL · Injection, Solution · Hospira, Inc.
- 71288-701 Atracurium Besylate 10 mg/mL · Injection, Solution · Meitheal Pharmaceuticals Inc.
- 71288-702 Atracurium Besylate 10 mg/mL · Injection, Solution · Meitheal Pharmaceuticals Inc.